Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 66,862,684
- Share change
- -545,923
- Total reported value
- $365,052,989
- Put/Call ratio
- 97%
- Price per share
- $5.46
- Number of holders
- 142
- Value change
- -$620,374
- Number of buys
- 76
- Number of sells
- 61
Report period
Q3 2022
Institutions
142
Top holders
10
KPTI full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
46%
|
10,362,009
|
$46,733,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
36%
|
8,122,849
|
$36,635,000 | — | 30 Jun 2022 | |
| Palo Alto Investors LP |
13F
|
Company |
25%
|
5,621,533
|
$25,353,000 | — | 30 Jun 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
19%
|
4,400,000
|
$19,844,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
19%
|
4,221,980
|
$19,041,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
11%
|
2,386,678
|
$10,763,000 | — | 30 Jun 2022 | |
| Commodore Capital LP |
13F
|
Company |
8.5%
|
1,935,609
|
$8,730,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
8.4%
|
1,895,378
|
$8,548,000 | — | 30 Jun 2022 | |
| Walleye Capital LLC |
13F
|
Company |
7.7%
|
1,745,415
|
$7,872,000 | — | 30 Jun 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
6.7%
|
1,527,040
|
$6,887,000 | — | 30 Jun 2022 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
6.6%
|
1,500,000
|
$6,765,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
6.4%
|
1,446,402
|
$6,523,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.9%
|
1,326,319
|
$5,981,000 | — | 30 Jun 2022 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
5.8%
|
1,315,834
|
$5,934,000 | — | 30 Jun 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
5.5%
|
1,235,630
|
$5,572,000 | — | 30 Jun 2022 | |
| Iron Triangle Partners LP |
13F
|
Company |
4.9%
|
1,100,000
|
$4,961,000 | — | 30 Jun 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
4.5%
|
1,023,752
|
$4,617,000 | — | 30 Jun 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4.4%
|
986,000
|
$4,447,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.4%
|
768,098
|
$3,463,000 | — | 30 Jun 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
3.1%
|
700,000
|
$3,157,000 | — | 30 Jun 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
2.9%
|
645,985
|
$2,913,000 | — | 30 Jun 2022 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
2.8%
|
632,506
|
$2,853,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.7%
|
605,383
|
$2,730,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
2.6%
|
594,488
|
$2,682,000 | — | 30 Jun 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
2.6%
|
584,288
|
$2,635,139 | — | 30 Jun 2022 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
2.3%
|
513,802
|
$2,317,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.1%
|
479,415
|
$2,162,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
2.1%
|
469,019
|
$2,115,000 | — | 30 Jun 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
2%
|
459,409
|
$2,072,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
454,800
|
$2,051,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
408,349
|
$1,842,000 | — | 30 Jun 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
389,164
|
$1,755,000 | — | 30 Jun 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
382,041
|
$1,723,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
1.4%
|
317,535
|
$1,432,000 | — | 30 Jun 2022 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
1.3%
|
286,659
|
$1,293,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
286,381
|
$1,291,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
281,936
|
$1,272,000 | — | 30 Jun 2022 | |
| Birchview Capital, LP |
13F
|
Company |
1.2%
|
269,332
|
$1,215,000 | — | 30 Jun 2022 | |
| HighVista Strategies LLC |
13F
|
Company |
1.1%
|
250,377
|
$1,129,000 | — | 30 Jun 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
242,997
|
$1,096,000 | — | 30 Jun 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1%
|
227,599
|
$1,026,000 | — | 30 Jun 2022 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
0.99%
|
224,603
|
$1,011,000 | — | 30 Jun 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.92%
|
208,597
|
$941,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.88%
|
199,977
|
$902,000 | — | 30 Jun 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.87%
|
196,342
|
$886,000 | — | 30 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.84%
|
190,479
|
$859,000 | — | 30 Jun 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.82%
|
185,296
|
$836,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.81%
|
184,165
|
$830,000 | — | 30 Jun 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.79%
|
179,225
|
$808,000 | — | 30 Jun 2022 | |
| Swiss National Bank |
13F
|
Company |
0.71%
|
160,750
|
$725,000 | — | 30 Jun 2022 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q3 2022
As of 30 Sep 2022,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,862,684 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., Palo Alto Investors LP, VANGUARD GROUP INC, Rubric Capital Management LP, Nuveen Asset Management, LLC, COMMODORE CAPITAL LP, CITADEL ADVISORS LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, and Ally Bridge Group (NY) LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
144
Q3 2022 holders
142
Holder diff
-2
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.